Alberti, S., et al.. The Antiplatelet Agent Revacept Prevents the Increase of Systemic Thromboxane A2 Biosynthesis and Neointima Hyperplasia. no. 1, Springer Science and Business Media LLC, Dec. 2020, doi:10.1038/s41598-020-77934-x.